Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro

Sun,Rong; Yang,Yang; Gu,Zheng; Tang,Xinye; Zhang,Cheng; Kou,Wei; Wei,Ping

doi:10.3892/mmr.2019.10638

Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro

Authors:
- Rong Sun
- Yang Yang
- Zheng Gu
- Xinye Tang
- Cheng Zhang
- Wei Kou
- Ping Wei
View Affiliations

Affiliations: Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Otorhinolaryngology, The Children's Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: September 2, 2019 https://doi.org/10.3892/mmr.2019.10638
Pages: 3893-3900

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the expression and role of the co‑stimulatory molecule T‑lymphocyte activation antigen CD86 (CD86) in dendritic cells (DCs) from the peripheral blood of patients with allergic rhinitis (AR) compared with those from healthy individuals. It was observed that mature DCs from the peripheral blood of patients with AR expressed high levels of the co‑stimulatory molecule CD86, but not CD80, compared with healthy control subjects. CD86 expression levels in DCs decreased significantly following transfection with siRNA in a lentiviral vector. Furthermore, the level of transforming growth factor‑β1 produced by T cells co‑cultured with DCs was significantly increased in the siRNA group, while interleukin (IL)‑4 and IL‑5 production was significantly decreased. The findings of the present study indicated that CD86 may play a pivotal role in the regulatory T cell/type 2 helper T cell imbalance in allergic inflammation.

View Figures

View References

1	Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, Durham SR and Nouri-Aria KT: Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy. 68:312–321. 2013. View Article : Google Scholar : PubMed/NCBI
2	Skrindo I, Ballke C, Gran E, Johansen FE, Baekkevold ES and Jahnsen FL: IL-5 production by resident mucosal allergen-specific T cells in an explant model of allergic rhinitis. Clin Exp Allergy. 45:1296–1304. 2015. View Article : Google Scholar : PubMed/NCBI
3	Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, et al: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 199:1567–1575. 2004. View Article : Google Scholar : PubMed/NCBI
4	Lee JH, Yu HH, Wang LC, Yang YH, Lin YT and Chiang BL: The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 148:53–63. 2007. View Article : Google Scholar : PubMed/NCBI
5	Sun R, Tang XY and Yang Y: Immune imbalance of regulatory T/type 2 helper cells in the pathogenesis of allergic rhinitis in children. J Laryngol Otol. 130:89–94. 2016. View Article : Google Scholar : PubMed/NCBI
6	Mellman I and Steinman RM: Dendritic cells: Specialized and regulated antigen processing machines. Cell. 106:255–258. 2001. View Article : Google Scholar : PubMed/NCBI
7	Lambrecht BN and Hammad H: The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet. 376:835–843. 2010. View Article : Google Scholar : PubMed/NCBI
8	Lim TS, Goh JK, Mortellaro A, Lim CT, Hämmerling GJ and Ricciardi-Castagnoli P: CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One. 7:e451852012. View Article : Google Scholar : PubMed/NCBI
9	Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell. 80:707–718. 1995. View Article : Google Scholar : PubMed/NCBI
10	Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC and Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 181:1145–1155. 1995. View Article : Google Scholar : PubMed/NCBI
11	Vermaelen K and Pauwels R: Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma. Am J Respir Cell Mol Biol. 29:405–409. 2003. View Article : Google Scholar : PubMed/NCBI
12	Gajewska BU, Swirski FK, Alvarez D, Ritz SA, Goncharova S, Cundall M, Snider DP, Coyle AJ, Gutierrez-Ramos JC, Stämpfli MR and Jordana M: Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol. 25:326–334. 2001. View Article : Google Scholar : PubMed/NCBI
13	Till SJ, Jacobson MR, O'Brien F, Durham SR, KleinJan A, Fokkens WJ, Juliusson S and Löwhagen O: Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy. 56:126–131. 2001. View Article : Google Scholar : PubMed/NCBI
14	Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P and Fokkens W: Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge. J Allergy Clin Immunol. 107:627–633. 2001. View Article : Google Scholar : PubMed/NCBI
15	KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, Jung S, Hoogsteden HC and Lambrecht BN: An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 118:1117–1125. 2006. View Article : Google Scholar : PubMed/NCBI
16	Suzuki M, Zheng X, Zhang X, Zhang ZX, Ichim TE, Sun H, Nakamura Y, Inagaki A, Beduhn M, Shunnar A, et al: A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol. 125:7372010. View Article : Google Scholar : PubMed/NCBI
17	Hosoya K, Satoh T, Yamamoto Y, Saeki K, Igawa K, Okano M, Moriya T, Imamura O, Nemoto Y and Yokozeki H: Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis. Allergy. 66:124–131. 2011. View Article : Google Scholar : PubMed/NCBI
18	Wang H, Zhang R, Wu J and Hu H: Knockdown of neurokinin-1 receptor expression by small interfering RNA prevents the development of allergic rhinitis in rats. Inflamm Res. 62:903–910. 2013. View Article : Google Scholar : PubMed/NCBI
19	Zhu XH, Liao B, Liu K and Liu YH: Effect of RNA interference therapy on the mice eosinophils CCR3 gene and granule protein in the murine model of allergic rhinitis. Asian Pac J Trop Med. 7:226–230. 2014. View Article : Google Scholar : PubMed/NCBI
20	Cho Y, Jang Y, Yang YD, Lee CH, Lee Y and Oh U: TRPM8 mediates cold and menthol allergies associated with mast cell activation. Cell Calcium. 48:202–208. 2010. View Article : Google Scholar : PubMed/NCBI
21	Srivastava S, Cai X, Li Z, Sun Y and Skolnik EY: Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells. Mol Cell Biol. 32:3132–3139. 2012. View Article : Google Scholar : PubMed/NCBI
22	Wang Y, Lin L and Zheng C: Downregulation of Orai1 expression in the airway alleviates murine allergic rhinitis. Exp Mol Med. 44:177–190. 2012. View Article : Google Scholar : PubMed/NCBI
23	Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 63 (Suppl 86):S8–S160. 2008. View Article : Google Scholar
24	Wong CK, Lun SW, Ko FW, Ip WK, Hui DS and Lam CW: Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol. 141:122–129. 2005. View Article : Google Scholar : PubMed/NCBI
25	Asai-Tajiri Y, Matsumoto K, Fukuyama S, Kan-O K, Nakano T, Tonai K, Ohno T, Azuma M, Inoue H and Nakanishi Y: Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma. Respir Res. 15:1322014. View Article : Google Scholar : PubMed/NCBI
26	Ritprajak P, Hashiguchi M and Azuma M: Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol Ther. 16:1323–1330. 2008. View Article : Google Scholar : PubMed/NCBI
27	Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K and Azuma M: Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol. 9:637–644. 1997. View Article : Google Scholar : PubMed/NCBI
28	Tsuyuki S, Tsuyuki J, Einsle K, Kopf M and Coyle AJ: Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med. 185:1671–1679. 1997. View Article : Google Scholar : PubMed/NCBI
29	Huh JC, Strickland DH, Jahnsen FL, Turner DJ, Thomas JA, Napoli S, Tobagus I, Stumbles PA, Sly PD and Holt PG: Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med. 198:19–30. 2003. View Article : Google Scholar : PubMed/NCBI
30	Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG and Gregory SA: Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice. J Pharmacol Exp Ther. 321:938–946. 2007. View Article : Google Scholar : PubMed/NCBI
31	Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature. 392:245–252. 1998. View Article : Google Scholar : PubMed/NCBI
32	Lutz MB and Schuler G: Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 23:445–449. 2002. View Article : Google Scholar : PubMed/NCBI
33	You S, Leforban B, Garcia C, Bach JF, Bluestone JA and Chatenoud L: Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci USA. 104:6335–6340. 2007. View Article : Google Scholar : PubMed/NCBI